Australian NSP survey national data report 1995-2010: prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees [pdf]
The Kirby Institute for infection and immunity in society, The University of New South Wales, 2011.

The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C (HCV) antibodies andmonitors sexual and injecting behaviour among people who inject drugs in Australia. Conducted annually since 1995, NSP services from all states and territories participate in the ANSPS. This report presents results for all survey years over the period 1995 to 2010.

The health of Australia's males [webpage]
Australian Institute of Health and Welfare (AIHW), June 2011

Drawing on a wide range of data sources, this report provides a snapshot of the health of Australia's males. Examples of the report's detailed findings include: males born between 2007-2009 can expect to live 24 years longer than males born between 1901-1910; around two-thirds of adult males and one-quarter of boys are overweight or obese; nearly half have ever had a mental health condition; nearly one-quarter have a disability and nearly one-third have a chronic health condition; 16% of males do not use any Medicare services in a year.
Includes chapters on smoking, alcohol and illicit drug use as well as mental health and alcohol and drug treatment facilities.

Injecting drug use and associated harms among Aboriginal Australians [pdf]
Australian National Council on Drugs, June 2011

This report highlights the need for greater investment in the prevention, treatment and harm reduction sector so that those most disadvantaged in our community are not further disadvantaged by an ineffective system. The findings from this project tell a similar story to many other research projects undertaken in this area. The next steps must be to move from analysis and consideration to action - that is, a structured and detailed approach to planning and delivering services that encompasses the complexity inherent among Aboriginal people who inject drugs, but is practical enough to make a difference.

National opioid pharmacotherapy statistics annual data collection: 2010 report [webpage]
Australian Institute of Health and Welfare (AIHW), June 2011

On a snapshot day in 2010 there were 46,078 clients who received pharmacotherapy for opioid dependence, of which almost two in three were male. This was an overall increase of just over 2,600 clients since 2009. This was accompanied by a rise in the number of prescribers from 1,435 in 2009 to 1,449 in 2010, with the majority of prescribers in 2010 being private prescribers (80%). Consistent with previous years, in 2010 methadone accounted for close to seven in 10 clients' pharmacotherapy type, with the remaining three in 10 clients receiving either buprenorphine or buprenorphine-naloxone.

Page updated 1st July 2011